Last quarter (Q4 2023), Adaptive Biotechnologies's total revenue was $45.78M, a decrease of -17.05% from the same quarter last year. In Q4, Adaptive Biotechnologies's net income was $-69.44M. See Adaptive Biotechnologies’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 170.28M	$ 170.28M	$ 185.31M	$ 154.34M	$ 98.38M	$ 85.07M
Cost of Revenue	$ 75.55M	$ 75.55M	$ 57.91M	$ 49.30M	$ 22.53M	$ 22.27M
Gross Profit	$ 94.72M	$ 94.72M	$ 127.40M	$ 105.04M	$ 75.85M	$ 62.80M
Operating Expense	$ 296.33M	$ 296.33M	$ 327.58M	$ 314.01M	$ 228.67M	$ 141.19M
Operating Income	$ -227.03M	$ -227.03M	$ -200.19M	$ -208.97M	$ -152.82M	$ -78.39M
Net Non Operating Interest Income Expense	$ 1.73M	$ 1.73M	$ -182.00K	$ 1.67M	$ 6.59M	$ 9.79M
Other Income Expense	$ 94.96M	$ 94.96M	$ 99.36M	-	-	-
Pretax Income	$ -174.45M	$ -174.45M	$ -200.37M	$ -207.30M	$ -146.23M	$ -68.61M
Tax Provision	-	-	-	-	$ 0.00	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -225.25M	$ -225.25M	$ -200.19M	$ -207.28M	$ -146.23M	$ -69.57M
Basic EPS	$ -1.56	$ -1.56	$ -1.40	$ -1.48	$ -1.11	$ -1.01
Diluted EPS	$ -1.56	$ -1.56	$ -1.40	$ -1.48	$ -1.11	$ -1.01
Basic Average Shares	$ 577.53M	$ 144.38M	$ 142.52M	$ 140.35M	$ 131.22M	$ 69.17M
Diluted Average Shares	$ 577.53M	$ 144.38M	$ 142.52M	$ 140.35M	$ 131.22M	$ 69.17M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 371.88M	$ 371.88M	$ 269.68M	$ 363.31M	$ 251.20M	$ 163.46M
Net Income From Continuing And Discontinued Operation	$ -225.25M	$ -225.25M	$ -200.19M	$ -207.28M	$ -146.23M	$ -68.61M
Normalized Income	$ -71.03M	$ -116.61M	-	-	$ -146.23M	$ -68.61M
Interest Expense	-	-	-	-	-	-
EBIT	$ -160.65M	$ -160.65M	$ -196.13M	$ -207.30M	$ -152.82M	$ -78.39M
EBITDA	$ -147.63M	$ -147.63M	$ -174.49M	$ -186.07M	$ -144.34M	$ -70.60M

Currency in USD

Adaptive Biotechnologies Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing